TY - JOUR T1 - Gastric bypass surgery is more efficacious than intensive lifestyle and medical treatment for type 2 diabetes remission JF - Evidence Based Medicine JO - Evid Based Med DO - 10.1136/eb-2013-101580 SP - ebmed-2013-101580 AU - Kristina H Lewis AU - David Arterburn Y1 - 2013/11/26 UR - http://ebm.bmj.com/content/early/2013/11/26/eb-2013-101580.abstract N2 - Commentary on: Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidaemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013;309:2240–49.OpenUrlCrossRefPubMedWeb of Science Despite numerous medication and lifestyle treatment options, just over half of patients with type 2 diabetes mellitus (T2DM) achieve a glycated haemoglobin (HbA1c) of <7%.1 Roux-en-y gastric bypass surgery (RYGB) has traditionally been reserved for treating severe obesity, but there is growing interest in using this and other bariatric procedures to treat T2DM in less obese patients.2 ,3 There have been few rigorous studies comparing RYGB against best available non-surgical treatment for control of T2DM and comorbid conditions. Ikramuddin and colleagues conducted a … ER -